Fox Chase Cancer Center Receives Re-Accreditation in Voluntary, Rigorous Program Evaluating Protection of Research Participants
PHILADELPHIA (July 5, 2007) — The human subjects protection program at Fox Chase Cancer Center has received full re-accreditation from the Association for Accreditation of Human Research Protection Programs (AAHRPP). Participation in the accreditation program is voluntary and involves a rigorous and thorough review of an institute's internal program for protecting patients who choose to enroll in clinical research.
During AAHRPP's recent three-day site visit, Fox Chase was found to meet or exceed all the requirements needed to receive re-accreditation, which is valid for three years. The re-accreditation recognizes that Fox Chase meets and in some areas surpasses state and federal laws on the oversight of human research, including clinical trials.
"The Association praised our commitment to protecting the rights and welfare of research participants," said W. Thomas London, M.D., chair of the institutional review board.
In July 2004, after an intensive accreditation process, Fox Chase Cancer Center was among the first institutions in the United States to be accredited by AAHRPP. The Center was the first freestanding comprehensive cancer center and the first program in Pennsylvania to receive accreditation.
AAHRPP is a nonprofit organization that works with organizations that conduct human research to raise the level of protection for research participants. AAHRPP accredits organizations that can demonstrate they provide participant safeguards that surpass the threshold of state and federal requirements. The accreditation program utilizes a voluntary, peer-driven, educational model. For organizations interested in learning more about AAHRPP accreditation, visit www.aahrpp.org.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Diana Quattrone at 215-728-7784.